Fig. 3
From: An ecological measure of immune-cancer colocalization as a prognostic factor for breast cancer
The association between immune-cancer cell colocalization and breast cancer prognosis is highly subtype-specific. Kaplan-Meier curves for the validation cohort alone are shown for human epidermal growth factor receptor 2-positive (Her2+) (a), basal (b), luminal A (c), and luminal B (d) Pam50 subtypes. The thresholds for dichotomizing two indices were optimized in the discovery cohort of the subtype and then used for both the discovery and validation cohorts (0.639985 for luminal A, 0.7439517 for luminal B, 0.699701 for basal and 0.7106531 for Her2)